NanoBio Nasal Antiseptic Launch Accelerated As COVID19 Spikes Demand For Personal Sanitizers

NanoBio Nasal Antiseptic Launch Accelerated As COVID-19 Spikes Demand For Personal Sanitizers

15:47 EDT 5 Apr 2020 | SCRIP

“When COVID-19 hit, we really decided to accelerate plans,” says BlueWillow CEO Dave Peralta. NanoBio Protect contains OTC monograph ingredient...

More From BioPortfolio on "NanoBio Nasal Antiseptic Launch Accelerated As COVID-19 Spikes Demand For Personal Sanitizers"